Recombinant Capital Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Recombinant Capital General Information

Description

Provider of analysis and advice for bio-pharmaceutical business development. The company's highly structured database of biopharma deals provide customers the insight they need to support their deals and strengthen their negotiation position for effective decision-making.

Contact Information

Website
www.recap.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 50 Fremont Street
  • San Francisco, CA 94105
  • United States
Primary Industry
Consulting Services (B2B)
Acquirer
Thomson Reuters
Vertical(s)
Industrials
Corporate Office
  • 50 Fremont Street
  • San Francisco, CA 94105
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Recombinant Capital Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Recombinant Capital‘s full profile, request access.

Request a free trial

Recombinant Capital Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Recombinant Capital‘s full profile, request access.

Request a free trial

Recombinant Capital FAQs

  • When was Recombinant Capital founded?

    Recombinant Capital was founded in 1988.

  • Who is the founder of Recombinant Capital?

    Mark Edwards is the founder of Recombinant Capital.

  • Where is Recombinant Capital headquartered?

    Recombinant Capital is headquartered in San Francisco, CA.

  • What industry is Recombinant Capital in?

    Recombinant Capital’s primary industry is Consulting Services (B2B).

  • Is Recombinant Capital a private or public company?

    Recombinant Capital is a Private company.

  • What is Recombinant Capital’s current revenue?

    The current revenue for Recombinant Capital is .

  • Who are Recombinant Capital’s investors?

    Deloitte has invested in Recombinant Capital.

  • When was Recombinant Capital acquired?

    Recombinant Capital was acquired on 07-Jun-2013.

  • Who acquired Recombinant Capital?

    Recombinant Capital was acquired by Thomson Reuters.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »